Alvotech, Teva reach settlement with Regeneron over Eylea...

2025-12-19 05:08:31 ET More on Teva Pharmaceutical, Alvotech, etc. Regeneron Pharmaceuticals, Inc. (REGN) Discusses Lynozyfic Development Strategy and Pipeline Opportunities in Multiple Myeloma - Slideshow Alvotech (ALVO) Discusses Launch of $125 Million Commercial Bond Offering and Business Update Transcript Regeneron Pharmaceuticals, Inc. (REGN) Discusses Lynozyfic Development Strategy and Pipeline Opportunities in Multiple Myeloma Transcript More pharmas expected to sign drug pricing deals with Trump on Friday - report Sagimet rises as licensing deal with Teva unit targets Madrigal drug Read the full article on Seeking Alpha For further details see: Alvotech, Teva reach settlement with Regeneron over Eylea biosimilar AVT06 in U.S.